Intas Pharmaceuticals has completed its acquisition of the UDENYCA (pegfilgrastim-cbqv) business from Coherus BioSciences Inc ...

Coherus BioSciences has completed the sale of its Udenyca (pegfilgrastim-cbqv) franchise to Intas Pharmaceuticals under an asset purchase agreement signed by the companies in December 2024 for up ...

After a batch of much-anticipated reciprocal tariffs spared pharmaceuticals in early April, drugmakers, medtech companies, manufacturers and other outfits across the life sciences spectrum are ...

Coherus BioSciences has completed the sale of its Udenyca (pegfilgrastim-cbqv) franchise to Intas Pharmaceuticals under an ...

Hetero Group founder, B Parthasaradhi Reddy, warns of potential US reciprocal tariffs on Indian pharmaceuticals, which could disrupt India's pharma industry, leading to higher prices and reduced ...

Stock market today: Indian pharma stocks extended their losing streak to the third consecutive trading session on Thursday, March 27, as concerns grew that US President Donald Trump may announce ...

But these same areas are now overcrowded, and price wars are common. Companies like Mankind, Sun Pharma, and Intas are looking at combinations of brand innovation, portfolio reshuffling ...

Analysts believe the key question is whether India can be exempted from the pharma tariffs, given the better relationship between the countries and the critical nature of India’s generic drug ...

Department of Pharmaceuticals (DoP) is set to commission a study to revamp the logistics value chain . (Image Source: Pixabay) Even as the pharma sector is still grappling with the uncertainty ...

Zero. That revelation was part of a Senate Finance Committee investigation done by Democratic staff, released in March, that examined how U.S. pharmaceutical giants exploit a loophole created by ...

A Russian missile struck a warehouse belonging to Kusum Healthcare, an Indian pharmaceutical company, in Ukraine, prompting condemnation from the Ukrainian embassy, which alleged a deliberate ...